S. Aktürk Esen Et Al. , "First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer.," Bosnian journal of basic medical sciences , vol.22, pp.818-825, 2022
Aktürk Esen, S. Et Al. 2022. First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer.. Bosnian journal of basic medical sciences , vol.22 , 818-825.
Aktürk Esen, S., Ergun, Y., Erol, C., Arikan, R., Er, M. M., Atci, M. M., ... Topçu, A.(2022). First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer.. Bosnian journal of basic medical sciences , vol.22, 818-825.
Aktürk Esen, Selin Et Al. "First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer.," Bosnian journal of basic medical sciences , vol.22, 818-825, 2022
Aktürk Esen, Selin A. Et Al. "First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer.." Bosnian journal of basic medical sciences , vol.22, pp.818-825, 2022
Aktürk Esen, S. Et Al. (2022) . "First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer.." Bosnian journal of basic medical sciences , vol.22, pp.818-825.
@article{article, author={Selin Aktürk Esen Et Al. }, title={First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer.}, journal={Bosnian journal of basic medical sciences}, year=2022, pages={818-825} }